Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm

Clinical trial NCT00163189 · COMPLETED

Trial details

NCT number: NCT00163189
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Growth Hormone Deficiency

Start date: 2005-01-01
Primary completion: 2014-12-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.